Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02256306 · ClinicalTrials.gov registry record · NA
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02256306: Completed NA study, sponsored by Stanford University.
NCT02256306 is a NA study that has completed, run by Stanford University. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02256306, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Mild-To-Moderate Alzheimer's Disease
Interventions
- OTHER Plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02256306
The ClinicalTrials.gov registry entry for NCT02256306 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Plasma is the first listed.
NCT02256306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02256306 about?
NCT02256306 is a clinical study titled "The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study". The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Mild-To-Moderate Alzheimer's Disease
What is the current status of trial NCT02256306?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-09. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02256306?
The interventions under investigation include: Plasma (OTHER).
Who is sponsoring clinical trial NCT02256306?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.